Drugs / LSD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07189299 | Oct 2025 → Nov 2029 expected | premenstrual dysphoric disorder | Friederike Holze | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LSD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07189299 ↗ |
| Action | Activate | “the serotonin 2A receptor agonist LSD” NCT07189299 ↗ |